BRIEF published on 06/06/2025 at 15:18, 9 months 5 days ago Le groupe Vanguard révèle sa position dans Aviva plc Titres Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Aviva Plc
PRESS RELEASE published on 06/06/2025 at 15:18, 9 months 5 days ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. discloses a 10.66% stake in Qualcomm Incorporated as of 05 June 2025, purchasing and selling common shares Common Shares Financial Dealings The Vanguard Group Stake Disclosure Qualcomm Incorporated
BRIEF published on 06/06/2025 at 15:17, 9 months 5 days ago The Vanguard Group Discloses Position in Deliveroo plc Disclosure Takeover Code Vanguard Group Shareholding Deliveroo
BRIEF published on 06/06/2025 at 15:17, 9 months 5 days ago Le groupe Vanguard révèle sa position dans Deliveroo plc Actionnariat Groupe Vanguard Code De Prise De Contrôle Divulgation Deliveroo
PRESS RELEASE published on 06/06/2025 at 15:17, 9 months 5 days ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses a 10.85% ownership position in American Axle & Manufacturing Holdings, Inc. as of 05 June 2025 Securities Disclosure The Vanguard Group Ownership Position American Axle & Manufacturing Holdings
BRIEF published on 06/06/2025 at 15:16, 9 months 5 days ago Vanguard Group's Position in Empiric Student Property Takeover Code Securities Disclosure Vanguard Group Investment Position Empiric Student Property
BRIEF published on 06/06/2025 at 15:16, 9 months 5 days ago Position du groupe Vanguard dans l'immobilier étudiant empirique Groupe Vanguard Code De Prise De Contrôle Divulgation Des Valeurs Mobilières Position D'investissement Propriété Empirique Des Étudiants
PRESS RELEASE published on 06/06/2025 at 15:15, 9 months 5 days ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses 4.48% stake in Mural Oncology plc as of 5 June 2025 under Form 8.3 to Irish Takeover Panel Form 8.3 Irish Takeover Panel Vanguard Group Stake Disclosure Mural Oncology Plc
BRIEF published on 06/06/2025 at 15:14, 9 months 5 days ago Vanguard Discloses Stake in LondonMetric Property Form 8.3 Takeover Code Vanguard Group LondonMetric Property Shareholding Disclosure
BRIEF published on 06/06/2025 at 15:14, 9 months 5 days ago Vanguard révèle sa participation dans LondonMetric Property Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Divulgation Des Actions Propriété LondonMetric
Published on 03/12/2026 at 13:16, 1 hour 27 minutes ago Reeflex Solutions Inc. Provides Bi-Weekly Status Update on MCTO
Published on 03/12/2026 at 13:00, 1 hour 43 minutes ago Justera Announces Director and Interim CEO Appointments
Published on 03/12/2026 at 12:30, 2 hours 13 minutes ago Nextech3D.ai Signs Three-Year Enterprise 3D Modeling and Augmented Reality E-Commerce Contract Valued at Approximately $175,000
Published on 03/12/2026 at 12:30, 2 hours 13 minutes ago Orogen Royalties Announces Non-Brokered Private Placement of up to $10 Million
Published on 03/12/2026 at 14:28, 15 minutes ago Form 8.3 - The Vanguard Group, Inc.: British Land Company plc, The
Published on 03/12/2026 at 13:51, 51 minutes ago REPLY: The Board of Directors approved the draft financial statements for the year 2025
Published on 03/12/2026 at 13:45, 58 minutes ago Vietnam Airlines Steps Up Market Promotion Efforts in Europe
Published on 03/12/2026 at 10:55, 3 hours 47 minutes ago Déclaration des transactions sur actions propres réalisées le 09/03/2026
Published on 03/12/2026 at 10:55, 3 hours 47 minutes ago Statement of transactions in own shares on March 9th, 2026
Published on 03/12/2026 at 08:30, 6 hours 13 minutes ago Claude Bernard lance Claude Bernard Compléments alimentaires en partenariat avec Synadiet
Published on 03/12/2026 at 07:30, 7 hours 13 minutes ago Biophytis-LynxKite Alliance Expands to Turbocharge AI-driven drug discovery for next generation longevity therapeutics
Published on 03/12/2026 at 07:30, 7 hours 13 minutes ago Biophytis et LynxKite renforcent leur alliance pour accélérer la découverte de médicaments dédiés à la longévité grâce à l’IA
